Lexeo Therapeutics

Lexeo links gene therapy to improvements in rare heart disease but disappoints investors
Fierce Biotech
Mon, 07/15/24 - 10:01 am
Lexeo Therapeutics
gene therapy
Friedreich’s ataxia
After a record run, fewer biotechs are going public. Here’s how they’re performing.
BioPharma Dive
Tue, 12/19/23 - 11:42 am
biotech
IPOs
Cargo Therapeutics
Lexeo Therapeutics
RazyeBio
Abivax
Neumora Therapeutics
Lexeo drops share price at last minute in attempt to raise $100M IPO
Fierce Biotech
Fri, 11/3/23 - 11:53 am
Lexeo Therapeutics
IPOs
gene therapy
Lexeo, Abivax File for IPOs on Nasdaq Amid Industry-Wide Drought
BioSpace
Mon, 10/2/23 - 10:40 am
IPOs
Lexeo Therapeutics
Abivax
genetic medicine